Docusate Sodium
Product Images NDC 10135-111

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Docusate Sodium (NDC 10135-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panelndc 10135-0111-01docusate Sodium100 mg100 Softgels (Docusate Sodium 01)

Docusate Sodium 100 mg softgels packaging label from Marlex Pharmaceuticals Inc. The label states the product is a stool softener laxative for relief of constipation. It contains 100 softgels and is stimulant free. The active ingredient is docusate sodium 100 mg per softgel.*

FDA Label Image

Principal Display Panelndc 10135-0111-01docusate Sodium100 mg100 Softgels (Docusate Sodium 02)

Drug Facts panel for Docusate Sodium by Marlex Pharmaceuticals Inc, detailing directions for use, dosing information by age group, warnings regarding usage, and storage conditions. It includes active ingredient information listing docusate sodium at 50 mg per softgel, other components, and inactive ingredients such as polyethylene glycol, purified water, gelatin, and sorbitol. The label advises to stop use and consult a doctor under certain conditions and warns about proper dosing and keeping the product out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.